Table 3. Prevalence of Early Phenotypic Abnormalities in Mutation Carriers and Controls.
G+/LVH+(n=81) | G+/LVH-(N=55) | Controls (n=42) | G+/LVH+ vs G+/LVH- P-value | G+/LVH+ vs Control P-value | G+/LVH- vs Control P-value | |
---|---|---|---|---|---|---|
LV Thickness:Diameter Ratio > 0.23 | 99% | 35% | 12% | < 0.001 | < 0.001 | 0.04 |
LVEDD z-score < -1.5 | 88% | 68% | 37% | 0.002 | < 0.001 | 0.009 |
Singulex Troponin I >3.0 pg/ml | 73% | 40% | 20% | 0.006 | < 0.001 | 0.05 |
LVESD z-score < -1.5 | 72% | 57% | 30% | 0.09 | < 0.001 | 0.004 |
NTproBNP>100 pg/ml | 58% | 14% | 8% | < 0.001 | < 0.001 | 0.45 |
QST Present on ECG | 46% | 14% | 3% | < 0.001 | < 0.001 | 0.09 |
Septal E′ z-score < -1.5 | 42% | 13% | 5% | < 0.001 | 0.002 | 0.17 |
QST, ECG Q waves or ST changes; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LV, left ventricular
P values and percentages were adjusted for patient age, sex, and familial relationships.
P values <0.017 are considered statistically significant, applying post hoc Bonferroni correction.